Hhm Wealth Advisors, LLC Editas Medicine, Inc. Transaction History

Hhm Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$9.99 - $21.35 $2,047 - $4,376	-205 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$26.55 - $40.57 $1,194 - $1,825	-45 Reduced 18.0%	205 $5,000
Q3 2021 Nov 02, 2021	BUY	$39.27 - $72.94 $6,675 - $12,399	170 Added 212.5%	250 $10,000
Q2 2021 Jul 27, 2021	BUY	$31.29 - $56.64 $2,503 - $4,531	80 New	80 $5,000

225

54.2M

412K

355K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $132M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Hhm Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Hhm Wealth Advisors, LLC with notifications on news.